Phibro Animal Health
PAHC
146 hedge funds and large institutions have $615M invested in Phibro Animal Health in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 52 reducing their positions, and 12 closing their positions.
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
20% more capital invested
Capital invested by funds: $513M → $615M (+$102M)
4% more funds holding
Funds holding: 141 → 146 (+5)
1.02% more ownership
Funds ownership: 103.71% → 104.73% (+1%)
4% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$10.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.34M |
| 3 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
+$8.11M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.62M |
| 5 |
Morgan Stanley
New York
|
+$3.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSC
Cove Street Capital
El Segundo,
California
|
-$13.2M |
| 2 |
BlackRock
New York
|
-$7M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.85M |
| 5 |
MSL
Mackay Shields LLC
New York
|
-$1.42M |
PAHC Hedge Fund Activity: Q2 2021 in Review
146 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2021, worth a combined $615M — up 20% from $513M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new PAHC positions and 12 closed out — a net gain of 6 holders — while 50 added to existing stakes and 52 trimmed.
The largest buyer was Pzena Investment Management, adding an estimated $10.5M. The largest seller was Cove Street Capital, cutting an estimated $13.2M.
- 146 institutional investors held Phibro Animal Health (PAHC) as of Q2 2021, up from 141 in Q1 2021.
- Funds reported $615M of Phibro Animal Health stock for Q2 2021, up 20% quarter-over-quarter.
- 18 funds opened new Phibro Animal Health positions in Q2 2021 and 12 closed out, a net change of +6 holders.
- The largest Phibro Animal Health buyer in Q2 2021 was Pzena Investment Management, an estimated $10.5M added.
- The largest Phibro Animal Health seller in Q2 2021 was Cove Street Capital, an estimated $13.2M sold.
Based on aggregated 13F filings for Q2 2021.